• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic tests for delirium: a review of the clinical evidence of accuracy and reliability
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy for non-small cell lung cancer: a review of the clinical effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Closed catheter systems for prevention of urinary tract infections: a review of the clinical effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain natriuretic peptide testing for congestive heart failure: a review of the guidelines and clinical and cost-effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti-psychotics in pediatric patients: a review of the clinical effectiveness, safety, and guidelines
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Antibiotic infused bone cement for orthopedic surgeries: a review of the clinical benefit and harm
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Organizational and economic issues in the management of patients with acute ST-segment elevation myocardial infarction (STEMI)]
2008     Medical Advisory Secretariat (MAS) OHTAC 2003 - 2008 Progress Report- advancing health: evidence-based advice on health technology
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single-use medical devices: clinical, economic, and health services impact
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) PRESS: Peer Review of Electronic Search Strategies
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimally invasive arthroplasty in the management of hip arthritic disease: systematic review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Milnacipran for Fibromyalgia
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous Erythropoietin Receptor Activator (Mircera) for Renal Anemia
2008     Institute of Health Economics (IHE) CT and MRI services in Alberta: comparisons with other health care systems
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Home telehealth for chronic disease management
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Granulocyte-colony stimulating factor for antiviral-associated neutropenia: Systematic review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomographic colonography for colorectal cancer screening in an average risk population: Systematic review and economic evaluation
2008     Technology Assessment at SickKids (TASK) Caspofungin in the empiric treatment of febrile neutropenia in paediatric patients: A comparison with conventional and liposomal amphotericin B
2008     Medical Advisory Secretariat (MAS) Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis
2008     Institute of Health Economics (IHE) Islet transplantation for the treatment of Type 1 diabetes - an update
2008     Medical Advisory Secretariat (MAS) Behavioural interventions for urinary incontinence in community-dwelling seniors: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) Caregiver- and patient-directed interventions for dementia: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) Social isolation in community-dwelling seniors: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) The falls/fractures economic model in Ontario residents aged 65 years and over (FEMOR)
2007     Institute of Health Economics (IHE) Screening newborns for hearing: the use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening
2007     Institute of Health Economics (IHE) Teleoncology: applications and associated benefits for the adult population
2007     Institute of Health Economics (IHE) Safety and efficacy of inhaled nitric oxide in the management of hypoxemic respiratory failure in adults with acute respiratory distress syndrome
2007     Institute of Health Economics (IHE) Screening newborns for cystic fibrosis
2007     Institute of Health Economics (IHE) Routine preoperative tests - are they necessary?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Adalimumab, alefacept, efalizumab, etanercept, and infliximab for severe psoriasis vulgaris in adults: budget impact analysis and review of comparative clinical- and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Thiazide diuretics as first-line treatment for hypertension: meta-analysis and economic evaluation
2007     Medical Advisory Secretariat (MAS) Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Prostaglandin analogues for ophthalmic use: analysis of clinical and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous renal replacement therapy in adult patients with acute renal failure: systematic review and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Laparoscopic adjustable gastric banding for weight loss in obese adults:clinical and economic review
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Atypical antipsychotic monotherapy for schizophrenia: clinical review and economic evaluation of first year of treatment
2007     Institute for Clinical Evaluative Sciences (ICES) Effectiveness and safety of drug-eluting stents in Ontario
2007     Institute for Clinical Evaluative Sciences (ICES) Quality assessment of administrative data (QuAAD): an opportunity for enhancing Ontario's health data
2007     Institute for Clinical Evaluative Sciences (ICES) The Ontario Wait Time Strategy: no evidence of an adverse impact on other surgeries
2007     Institute for Clinical Evaluative Sciences (ICES) Diagnostic services in Ontario: descriptive analysis and jurisdictional review
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Lubiprostone
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Sacral nerve stimulation in fecal incontinence
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparative overview of cancer control strategies in selected jurisdictions
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Anal dysplasia screening: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Low-density lipoprotein apheresis: an evidence-based analysis
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The practice of percutaneous coronary interventions in hospitals without on-site cardiac surgery: review of guidelines and analysis of Quebec data, 1999-2004]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Population screening for primary open-angle glaucoma
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of costeffectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The role of hyperbaric oxygen therapy in the management of autism
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2007     Medical Advisory Secretariat (MAS) Systematic review and cost-effectiveness analysis of elective endovascular repair compared to open surgical repair of abdominal aortic aneurysms: Final report
2007     Medical Advisory Secretariat (MAS) Clinical and cost-effectiveness analysis of drug eluting stents compared to bare metal stents for percutaneous coronary interventions in Ontario: final report
2007     Medical Advisory Secretariat (MAS) In-room HEPA cleaners: current and recommended practices
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Capsule colonoscopy: PillCam (TM) colon
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Nicotine vaccines for smoking cessation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Nuchal translucency measurement in first trimester Down Syndrome screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacogenomics and warfarin therapy
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Ranolazine (Ranexa (TM)) for chronic stable angina
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Sipuleucel-T (Provenge (TM)): active cellular immunotherapy for advanced prostate cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm (TM) real-time system
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Yttrium-90 microspheres (TheraSphere (TM) and SIR-Spheres (TM)) for the treatment of unresectable hepatocellular carcinoma
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic rotator cuff tendonitis (shoulder pain)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic lateral epicondylitis (tennis elbow)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Obstructive sleep apnea: a palatable treatment option?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Human a1-proteinase inhibitor for patients with a1-antitrypsin deficiency
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Preschool vision screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of adjunctive hyperbaric oxygen therapy for diabetic foot ulcer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Adjunctive hyperbaric oxygen therapy for diabetic foot ulcer: an economic analysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as a diagnostic and therapeutic tool for spinal pain: a review of clinical and cost effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pulsed dye laser therapy for port wine stains
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of neuraminidase inhibitors for prevention of influenza
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Palivizumab prophylaxis against respiratory syncytial virus
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of implantable cardiac defibrillators for primary prevention of sudden cardiac death in high risk patients: clinical efficacy, cost-effectiveness, and psychosocial issues.
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Implantable cardiac defibrillators for primary prevention of sudden cardiac death in high risk patients: a meta-analysis of clinical efficacy, and a review of cost-effectiveness and psychosocial issues
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical and cost-effectiveness of interferon-based therapies for chronic hepatitis C virus infection
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pegylated interferon combined with ribavirin for chronic hepatitis C virus infection: an economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of long-acting Beta2-agonists (LABA) plus corticosteroids versus LABA alone for chronic obstructive pulmonary disease
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonists (LABA) plus corticosteroids versus LABA alone for chronic obstructive pulmonary disease
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pancreas transplantation to restore glucose control: review of clinical and economic evidence
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Mobility assistance dogs for mobility-impaired people
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab and etanercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Three-wheel and four-wheel scooters: alternatives to powered wheelchairs?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab and etanercept in rheumatoid arthritis: timing, dose escalation, and switching
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Viscosupplementation for the treatment of osteoarthritis of the knee
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Grazax: an oral vaccine for the treatment of grass pollen allergy (Hay fever)
2007     Medical Advisory Secretariat (MAS) Optimal health system design for preventive health screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable home hemodialysis for kidney failure
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of image-free computer-assisted systems in total knee replacement surgeries
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Human papillomavirus (HPV) vaccines: A Canadian update